系统性硬化症的动物模型：其效用与局限性
Animal models of systemic sclerosis: their utility and limitations.
作者信息
Artlett Carol M
机构信息
Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, USA.
出版信息
Open Access Rheumatol. 2014 Jul 1;6:65-81. doi: 10.2147/OARRR.S50009. eCollection 2014.
Abstract
Without doubt, animal models have provided significant insights into our understanding of the rheumatological diseases; however, no model has accurately replicated all aspects of any autoimmune disease. Recent years have seen a plethora of knockouts and transgenics that have contributed to our knowledge of the initiating events of systemic sclerosis, an autoimmune disease. In this review, the focus is on models of systemic sclerosis and how they have progressed our understanding of fibrosis and vasculopathy, and whether they are relevant to the pathogenesis of systemic sclerosis.
摘要
毫无疑问，动物模型为我们理解风湿性疾病提供了重要的见解；然而，没有一种模型能准确复制任何自身免疫性疾病的所有方面。近年来，出现了大量的基因敲除和转基因动物模型，这些模型有助于我们了解系统性硬化症（一种自身免疫性疾病）的起始事件。在这篇综述中，重点是系统性硬化症的模型，以及它们如何推动我们对纤维化和血管病变的理解，以及它们是否与系统性硬化症的发病机制相关。
相似文献
1
Animal models of systemic sclerosis: their utility and limitations.系统性硬化症的动物模型：其效用与局限性
Open Access Rheumatol. 2014 Jul 1;6:65-81. doi: 10.2147/OARRR.S50009. eCollection 2014.
2
Animal models of systemic sclerosis: insights into systemic sclerosis pathogenesis and potential therapeutic approaches.系统性硬化症的动物模型：对系统性硬化症发病机制及潜在治疗方法的见解
Curr Opin Rheumatol. 2004 Nov;16(6):746-52. doi: 10.1097/01.bor.0000137893.68929.86.
3
Animal models of scleroderma: fresh insights.硬皮病的动物模型：新的见解。
Curr Opin Rheumatol. 2010 Nov;22(6):677-82. doi: 10.1097/BOR.0b013e32833e307b.
4
Recent advances in mouse models for systemic sclerosis.系统性硬化症小鼠模型的最新进展。
Autoimmun Rev. 2018 Dec;17(12):1225-1234. doi: 10.1016/j.autrev.2018.06.013. Epub 2018 Oct 12.
5
Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis.特定风湿性疾病中的血管病变与血管生成紊乱：类风湿关节炎和系统性硬化症
Arthritis Res Ther. 2007;9 Suppl 2(Suppl 2):S3. doi: 10.1186/ar2187.
6
The role of platelets in autoimmunity, vasculopathy, and fibrosis: Implications for systemic sclerosis.血小板在自身免疫、血管病变和纤维化中的作用：对系统性硬化症的影响。
Semin Arthritis Rheum. 2017 Dec;47(3):409-417. doi: 10.1016/j.semarthrit.2017.05.004. Epub 2017 May 23.
7
Critical Appraisal of the Utility and Limitations of Animal Models of Scleroderma.硬皮病动物模型的实用性和局限性的批判性评价。
Curr Rheumatol Rep. 2016 Jan;18(1):4. doi: 10.1007/s11926-015-0553-9.
8
Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy.微小 RNA 在全身性硬皮病组织纤维化和血管病变发病机制中的作用。
Autoimmun Rev. 2019 Nov;18(11):102396. doi: 10.1016/j.autrev.2019.102396. Epub 2019 Sep 11.
9
Mouse model of experimental dermal fibrosis: the bleomycin-induced dermal fibrosis.实验性皮肤纤维化的小鼠模型：博来霉素诱导的皮肤纤维化。
Methods Mol Biol. 2014;1142:91-8. doi: 10.1007/978-1-4939-0404-4_11.
10
Pathogenesis of systemic sclerosis-current concept and emerging treatments.系统性硬化症的发病机制——当前概念与新兴治疗方法
Immunol Res. 2017 Aug;65(4):790-797. doi: 10.1007/s12026-017-8926-y.
引用本文的文献
1
Angiopoietin-like protein 2 mediates vasculopathy-driven fibrogenesis in a mouse model of systemic sclerosis.血管生成素样蛋白2在系统性硬化症小鼠模型中介导血管病变驱动的纤维化形成。
J Clin Invest. 2025 Jun 20;135(15). doi: 10.1172/JCI177123. eCollection 2025 Aug 1.
2
Lapatinib ameliorates skin fibrosis by inhibiting TGF-β1/Smad and non-Smad signaling pathway.拉帕替尼通过抑制TGF-β1/Smad和非Smad信号通路改善皮肤纤维化。
Sci Rep. 2025 Mar 11;15(1):8444. doi: 10.1038/s41598-025-92687-1.
3
Preclinical study of engineering MSCs promoting diabetic wound healing and other inflammatory diseases through M2 polarization.工程化间充质干细胞通过M2极化促进糖尿病伤口愈合及其他炎症性疾病的临床前研究
Stem Cell Res Ther. 2025 Mar 5;16(1):113. doi: 10.1186/s13287-025-04248-y.
4
PIK-III exerts anti-fibrotic effects in activated fibroblasts by regulating p38 activation.PIK-III 通过调节 p38 的激活来发挥其在激活的成纤维细胞中的抗纤维化作用。
PLoS One. 2024 Sep 6;19(9):e0306624. doi: 10.1371/journal.pone.0306624. eCollection 2024.
5
Phage Immunoprecipitation-Sequencing Reveals CDHR5 Autoantibodies in Select Patients With Interstitial Lung Disease.噬菌体免疫沉淀测序揭示了部分间质性肺疾病患者体内的CDHR5自身抗体。
ACR Open Rheumatol. 2024 Sep;6(9):568-580. doi: 10.1002/acr2.11696. Epub 2024 Jul 1.
6
Identification of Collagen-Suppressive Agents in Keloidal Fibroblasts Using a High-Content, Phenotype-Based Drug Screen.使用基于表型的高内涵药物筛选方法鉴定瘢痕疙瘩成纤维细胞中的胶原蛋白抑制因子
JID Innov. 2023 Nov 22;4(2):100248. doi: 10.1016/j.xjidi.2023.100248. eCollection 2024 Mar.
7
Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosis.静脉注射免疫球蛋白可改善系统性硬化症实验模型的皮肤纤维化。
Sci Rep. 2023 Sep 12;13(1):15102. doi: 10.1038/s41598-023-42464-9.
8
Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis.抗体介导的半乳糖凝集素-3 中和作用作为系统性硬化症治疗策略。
Nat Commun. 2023 Aug 31;14(1):5291. doi: 10.1038/s41467-023-41117-9.
9
European Society of Sexual Medicine consensus statement on the use of animal models for studying Peyronie's disease.欧洲性医学学会关于使用动物模型研究佩罗尼氏病的共识声明。
Sex Med. 2023 Aug 2;11(4):qfad046. doi: 10.1093/sexmed/qfad046. eCollection 2023 Aug.
10
Structural and functional characteristics of the pulmonary hemomicrocirculatory bed in induced systemic sclerosis: an experimental study.诱导性系统性硬化症肺血微循环床的结构和功能特征：一项实验研究。
Rheumatol Int. 2023 Jul;43(7):1341-1347. doi: 10.1007/s00296-023-05328-z. Epub 2023 Apr 18.
本文引用的文献
1
Reproduction of epstein-barr virus infection and pathogenesis in humanized mice.人类化小鼠中的 Epstein-Barr 病毒感染与发病机制的复制。
Immune Netw. 2014 Feb;14(1):1-6. doi: 10.4110/in.2014.14.1.1. Epub 2014 Feb 21.
2
Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease.通过渗透微型泵输送博来霉素：与人类硬皮病性间质性肺病的相似性。
Am J Physiol Lung Cell Mol Physiol. 2014 Apr 15;306(8):L736-48. doi: 10.1152/ajplung.00210.2013. Epub 2014 Feb 28.
3
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group.利妥昔单抗治疗系统性硬化症的疗效和安全性：来自欧洲硬皮病试验和研究（EUSTAR）组的分析。
Ann Rheum Dis. 2015 Jun;74(6):1188-94. doi: 10.1136/annrheumdis-2013-204522. Epub 2014 Jan 17.
4
Acquired Glanzmann thrombasthenia associated with Hodgkin lymphoma: rapid reversal of functional platelet defect with ABVD (adriamycin/bleomycin/vinblastine/dacarbazine) chemotherapy.获得性Glanzmann血小板无力症合并霍奇金淋巴瘤：ABVD（阿霉素/博来霉素/长春花碱/达卡巴嗪）化疗可迅速逆转功能性血小板缺陷
Clin Lymphoma Myeloma Leuk. 2014 Apr;14(2):e51-4. doi: 10.1016/j.clml.2013.10.004. Epub 2013 Nov 14.
5
Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis.丙硫氧嘧啶可预防活性氧物种诱导的系统性硬化症小鼠模型的皮肤和肺纤维化。
Arthritis Res Ther. 2013 Sep 16;15(5):R120. doi: 10.1186/ar4300.
6
Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in scleroderma.EB 病毒感染诱导硬皮病中异常的 TLR 激活途径和成纤维细胞-肌成纤维细胞转化。
J Invest Dermatol. 2014 Apr;134(4):954-964. doi: 10.1038/jid.2013.423. Epub 2013 Oct 11.
7
Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma.整合素调节疗法可预防硬皮病小鼠模型的纤维化和自身免疫。
Nature. 2013 Nov 7;503(7474):126-30. doi: 10.1038/nature12614. Epub 2013 Oct 9.
8
Pleiotropic effects of peroxisome proliferator-activated receptor γ and δ in vascular diseases.过氧化物酶体增殖物激活受体 γ 和 δ 在血管疾病中的多效性作用。
Circ J. 2013;77(11):2664-71. doi: 10.1253/circj.cj-13-0647. Epub 2013 Oct 10.
9
Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation.线粒体活性氧诱导 NLRP3 依赖性溶酶体损伤和炎症小体激活。
J Immunol. 2013 Nov 15;191(10):5230-8. doi: 10.4049/jimmunol.1301490. Epub 2013 Oct 2.
10
Relaxin attenuates silica-induced pulmonary fibrosis by regulating collagen type I and MMP-2.松弛素通过调节Ⅰ型胶原和 MMP-2 减轻二氧化硅诱导的肺纤维化。
Int Immunopharmacol. 2013 Nov;17(3):537-42. doi: 10.1016/j.intimp.2013.07.020. Epub 2013 Aug 20.
Zotero 插件